🌟 Celebrating Collaboration & Mentorship in Cardiology & Transplant Medicine 🌟
🫀The @SLUTransplantRx is a truly remarkable multidisciplinary collaboration — led by @MinaBenjaminMD, w/ outstanding project management from Barbara Okeke, and powered by the incredible engagement of students, residents, ➕ faculty support incl. @UchennaAgbim, CJ Lin, myself, & many others.
🫶On August 25, 2025, I was honored to join @RaviNayakMD Nayak in sharing reflections on #mentorship and career pathway experiences.
🏅The event special recognition of the service and contributions of Barbara C. Okeke & @AvaDelonai6124 .
🙏🏽 Special thanks as well to @mchowatt for joining the session.
🌍The team also had an amazing presence at the #WorldTransplantCongress2025 earlier in August — stay tuned for more updates to come! #SLUProud of this amazing group! 🫶
#SLUResearch #Transplantation #Mentorship #Collaboration #ClinicalInnovation | @slusom | @SLUCards | @slunephrons | @im_slu | @SLUResearch |@SSMHealth 🏥🩺
🎤 Gavin Christy presented at #WTC2025 “Association of Antiplatelets with Cardiovascular Adverse Outcomes and Mortality in Kidney Transplant Recipients.”
🔑 Antiplatelets were linked to a reduction in a composite of all-cause mortality & MACE
🛡️ No increase in major bleeding
🎤 Dr. Andres Mata of our group presented “Association of Statins with Adverse Outcomes following Kidney Transplantation” at WTC!
🔑 Statin use at time of KT was not associated with reduced MACE or all-cause mortality!
#KidneyTransplant#Statins#Cardiology#MACE#MedTwitter
🎉 Congratulations to Emma and Anna from our research team for presenting their work at #NKF!
📊 In a cohort of 518 kidney transplant recipients, they found diabetes as the cause of ESRD was associated with significantly higher mortality and cardiovascular events post-transplant.
New paper alert! 🚨 Our study in Cardiovascular Research examined clinical outcomes in cardiac amyloidosis versus non-ischemic cardiomyopathies.
@MinaBenjaminMD@SLUCards@im_slu https://t.co/z50hOW9kbb
New paper alert! 🚨 Our study in the American Journal of Cardiovascular Disease examined clinical outcomes in cardiac sarcoidosis patients treated with different immunosuppressive drugs.
@MinaBenjaminMD@sarcoid_papers@martinecaitlan@StopSarcoidosis
https://t.co/2X1V9tPBZa